Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2007-07-17
2007-07-17
Aulakh, Charanjit S. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
C514S075000, C514S130000, C514S816000
Reexamination Certificate
active
10991348
ABSTRACT:
The present invention is directed to novel water-soluble prodrugs of aliphatic or aromatic hindered hydroxyl group containing pharmaceuticals.
REFERENCES:
patent: 2829151 (1958-04-01), Britton et al.
patent: 3271314 (1966-09-01), Ecke et al.
patent: 3576923 (1971-04-01), Randell et al.
patent: 3723578 (1973-03-01), Eiseman et al.
patent: 4171272 (1979-10-01), Wright
patent: 4894456 (1990-01-01), Wall et al.
patent: 4912245 (1990-03-01), Girardeau et al.
patent: 4981968 (1991-01-01), Wall et al.
patent: 5039343 (1991-08-01), Umeda et al.
patent: 5049668 (1991-09-01), Wall et al.
patent: 5053512 (1991-10-01), Wani et al.
patent: 5091211 (1992-02-01), Richard
patent: 5106742 (1992-04-01), Wall et al.
patent: 5120464 (1992-06-01), Kamegai et al.
patent: 5122526 (1992-06-01), Wall et al.
patent: 5122606 (1992-06-01), Wani et al.
patent: 5180722 (1993-01-01), Wall et al.
patent: 5244903 (1993-09-01), Wall et al.
patent: 5364858 (1994-11-01), Wall et al.
patent: 5401747 (1995-03-01), Wall et al.
patent: 5554576 (1996-09-01), Mookerjee et al.
patent: 5589598 (1996-12-01), Paiocchi
patent: 5637625 (1997-06-01), Haynes
patent: 5646159 (1997-07-01), Wall et al.
patent: 5646176 (1997-07-01), Golik et al.
patent: 5731355 (1998-03-01), Jones et al.
patent: 5746973 (1998-05-01), Naraghi
patent: 5804682 (1998-09-01), Fischer et al.
patent: 6204257 (2001-03-01), Stella et al.
patent: 6451776 (2002-09-01), Stella et al.
patent: 0604910 (1994-07-01), None
patent: 0604910 (1994-07-01), None
patent: 604910 (1994-07-01), None
patent: 639577 (1995-02-01), None
patent: 747385 (1996-12-01), None
Bioorganic & Medicinal Chemistry Letters, 6(15), Aug. 6, 1996, pp. 1837-1842 Golik et al “Synthesis and antitumor evaluation of paclitaxel . . . ”.
Pharmaceutical Research, 10(9), Sep. 1993, pp. 1350-1355 Safadi et al “Phosphoryloxymethyl carbamates and carbonates . . . ”.
Abstract/Japanese Kokai Tokkyo Koho patent JP-11181293 Jul. 6, 1999.
Abstract/PCT Int. Appl. WO-9929640 Jun. 17, 1999.
Abstract/PCT Int. Appl. WO-9915609 Apr. 1, 1999.
Abstract/Japanese Kokai Tokkyo Koho patent JP-10298450 Nov. 10, 1998.
Abstract/U.S. patent 5804682 Sep. 8, 1998.
Abstract/Japanese Kokai Tokkyo Koho patent JP-10182981 Jul. 7, 1998.
Abstract/U.S. patent 5746973 May 5, 1998.
Abstract/Japanese Kokai Tokkyo Koho JP-10037072 Feb. 10, 1998.
Abstract/U.S. patent 5723538 Mar. 3, 1998.
Abstract/Japanese Kokai Tokkyo Koho JP-09188968 Jul. 22, 1997.
Abstract/Japanese Kokai Tokkyo Koho JP-09099441 Apr. 15, 1997.
Abstract/U.S. patent 5611992 Mar. 18, 1997.
Abstract/U.S. patent 5611991 Mar. 18, 1997.
Abstract/PCT Int. Appl. WO-9628603 Sep. 19, 1996.
Abstract/Japanese Kokai Tokkyo Koho JP-08011437 Jan. 16, 1994.
Abstract/German patent DE-4426134 Jan. 25, 1996.
Abstract/Czech patent CS-277269 Dec. 16, 1992.
Abstract/Japan Kokai Tokkyo Koho JP-05222068 Aug. 31, 1993.
Abstract/Japanese Kokai Tokkyo Koho JP-05051899 Mar. 2, 1993.
Abstract/Japanese Kokai Tokkyo Koho JP-04325600 Nov. 13, 1992.
Abstract/Japanese Kokai Tokkyo Koho JP-04282390 Oct. 7, 1992.
Abstract/Japanese Kokai Tokkyo Koho JP-04134088 May 7, 1992.
Abstract/Japanese Kokai Tokkyo Koho JP-04221390 Aug. 11, 1992,
Abstract/U.S. patent 5110503 May 5, 1992.
Abstract/Japanese Kokai Tokkyo Koho JP-04069389 Mar. 4, 1992.
Abstract/PCT Int. Appl.WO-9206596 Apr. 30,1 992.
Abstract/Japanese Kokai Tokkyo Koho JP-04055401 Feb. 24, 1992.
Abstract/Japanese Kokai Tokkyo Koho JP-04049223 Feb. 18, 1992.
Abstract/Japanese Kokai Tokkyo Koho JP-04041798 Feb. 12, 1992.
Abstract/U.S. patent 5091211 Feb. 25, 1992.
Abstract/Japanese Kokai Tokkyo Koho JP-03155987 Jul. 3, 1991.
Abstract/Japanese Kokai Tokkyo Koho JP-03197403 Aug. 28, 1991.
Abstract/Japanese Kokai Tokkyo Koho JP-03178904 Aug. 2, 1991.
Abstract/Eur. Pat. Appl. EP-393579 Oct. 24, 1990.
Abstract/German patent DE-3900941 Jul. 19, 1990.
Abstract/Eur. Pat. Appl. EP-365413 Apr. 25, 1990.
Abstract/Eur. Pat. Appl. EP-324451 Jul. 19, 1989.
Abstract/Japanese Kokai Tokkyo Koho JP-63185916 Aug. 1, 1988.
Abstract/Japanese Kokai Tokkyo Koho JP-63165477 Jul. 8, 1988.
Abstract/Japanese Kokai Tokkyo Koho JP-63156710 Jun. 29, 1988.
Abstract/Patentschrift(Switz.) CH-664577 Mar. 15, 1988.
Abstract/Eur. Pat. Appl. EP-252824 Jan. 13, 1988.
Ph.D. Dissertation of S. Varia, University of Kansas, May 26, 1981 “Water Soluble Prodrugs of 5, 5-Diphenylhydantoin”.
S. Sawada et al., “Synthesis and Antitumor Activity of A-Ring or E. Lactone Modified Water Soluble Prodrugs of 20(S)-Camptothecin, Including Development of Irinotecan Hydrochloride Tribydrate (CPT-11),” Current Pharmaceutical Design Vol. 1(1995), pp. 113-132.
Georg Ingrid Gunda
Safadi Muhammad S.
Stella Valentino J.
Zygmunt Jan J.
Aulakh Charanjit S.
Birch & Stewart Kolasch & Birch, LLP
University of Kansas
LandOfFree
Water soluble prodrugs of hindered alcohols does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Water soluble prodrugs of hindered alcohols, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Water soluble prodrugs of hindered alcohols will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3770704